Search results for

Just a few days after a food blogger created a buzz with an online petition raising questions about the safety of a food additive commonly used in commercial baking, sandwich giant Subway has announced plans to phase it out of its fresh-baked breads.

The video seems to mark the first time a canine has been used in a prisoner of war video. The Pentagon said U.S. forces lost a working dog in December.

A pair of U.S. diplomats are heard discussing the merits of various Ukrainian opposition figures. One of them is heard using a profanity directed toward the European Union.

Mathew Martoma, a former portfolio manager at the hedge fund, was found guilty of helping his employer reap hundreds of millions dollars in illegal profits.

Cutting the national debt and deficit used to be the most divisive political debate in Washington. These days, not so much. Both parties have agreed to move on and focus on issues they largely agree on: income inequality and social mobility. But there's not much they can do without a sustainable budget.

Samantha Power tells NPR the U.S. is enlisting the help of Russia in particular to secure humanitarian access to civilians trapped in the fighting.

Friday is the statutory deadline for the Treasury's borrowing authority, but Congress has no agreement on how to raise the limit. House Republicans appear unwilling to force another showdown over the debt ceiling, but they have not yet found a way to save face, and there are few legislative days left before Treasury exhausts its means to pay the bills.

While the jobless rate edged down to 6.6 percent in January from December's 6.7 percent, only 113,000 jobs were added to payrolls. That's well below what was expected.

"That doesn't mean I'm the only guy that can do it," the vice president tells CNN. "But if no one else, I think, can, and I think I can, then I'd run." He's far behind former Secretary of State Hillary Clinton in a recent poll of Democrats. Biden said he'll decide by summer 2015.

The U.S. recently approved a drug that can quickly cure hepatitis C in many patients. But its high price means the treatment is out of reach for millions of people in the developing world. Now the pill's manufacturer is talking with Indian producers to reduce the treatment cost to $2,000. But critics say the price drop won't be enough.